Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Commun Biol ; 5(1): 968, 2022 09 15.
Article in English | MEDLINE | ID: mdl-36109586

ABSTRACT

Programmable RNA editing offers significant therapeutic potential for a wide range of genetic diseases. Currently, several deaminase enzymes, including ADAR and APOBEC, can perform programmable adenosine-to-inosine or cytidine-to-uridine RNA correction. However, enzymes to perform guanosine-to-adenosine and uridine-to-cytidine (U-to-C) editing are still lacking to complete the set of transition reactions. It is believed that the DYW:KP proteins, specific to seedless plants, catalyze the U-to-C reactions in mitochondria and chloroplasts. In this study, we designed seven DYW:KP domains based on consensus sequences and fused them to a designer RNA-binding pentatricopeptide repeat (PPR) domain. We show that three of these PPR-DYW:KP proteins edit targeted uridine to cytidine in bacteria and human cells. In addition, we show that these proteins have a 5' but not apparent 3' preference for neighboring nucleotides. Our results establish the DYW:KP aminase domain as a potential candidate for the development of a U-to-C editing tool in human cells.


Subject(s)
Cytidine , RNA Editing , Adenosine/metabolism , Bacteria/genetics , Bacteria/metabolism , Cytidine/genetics , Cytidine/metabolism , Guanosine/metabolism , Humans , Inosine , Nucleotides/metabolism , Plant Proteins/genetics , RNA/metabolism , Uridine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL